Poland vs Samoa: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Poland
89.0%
in 2025
Samoa
89.0%
in 2025
Poland rank
72nd
Samoa rank
72nd
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Poland
- Samoa
How they compare
Poland currently reports 89.0% against 89.0% in Samoa, a difference of 0.0%.
The two have swapped places 4 times across 18 shared years of data; in 2008 it was Samoa ahead.
Poland ranks 72nd and Samoa ranks 72nd of 194 countries.
Poland has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Poland | Samoa | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 14.9% | 0.0% | 14.9% | Poland |
| 2020s | 88.5% | 49.3% | 39.2% | Poland |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Poland or Samoa?
- Poland, at 89.0% against 89.0% in Samoa as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Poland and Samoa?
- 0.0%, with Poland ahead.
- How many years of comparable data are there for Poland and Samoa?
- 18 years are reported by both, from 2008 to 2025.
- How do Poland and Samoa rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Poland ranks 72nd and Samoa ranks 72nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.